The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Webcast
AHRMM presents a four-part series on successful collaboration with suppliers.
Webcast
Annie Weisbrod, principal scientist at Procter and Gamble, discusses the science behind sustainable hygiene products in this free AHRMM webcast.
Webcast
AHRMM presents a four-part series on successful collaboration with suppliers.
Webcast
In part two of a four-part series on successful collaboration with suppliers, Mike Schiller, former director of supply chain at AHRMM, discusses re
White Papers
2018 AHRMM CQO Summit:
Each year at the annual AHRMM Cost, Quality and Outcom
Webcast
Having conversations with clinicians can be difficult, Howard Mann, a 30 year supply chain professional, discusses how to prepare for physician con